These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21443419)

  • 1. Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusion.
    Eriksson O; Långström B; Josephsson R
    Ups J Med Sci; 2011 May; 116(2):100-6. PubMed ID: 21443419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography.
    Learned-Coughlin SM; Bergström M; Savitcheva I; Ascher J; Schmith VD; Långstrom B
    Biol Psychiatry; 2003 Oct; 54(8):800-5. PubMed ID: 14550679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.
    Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM
    Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.
    Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
    Synapse; 2001 Dec; 42(4):273-80. PubMed ID: 11746726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PET.
    Appel L; Bergström M; Buus Lassen J; Långström B
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):251-61. PubMed ID: 24239329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
    Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
    Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.
    Sasaki T; Ito H; Kimura Y; Arakawa R; Takano H; Seki C; Kodaka F; Fujie S; Takahata K; Nogami T; Suzuki M; Fujiwara H; Takahashi H; Nakao R; Fukumura T; Varrone A; Halldin C; Nishikawa T; Suhara T
    J Nucl Med; 2012 Jul; 53(7):1065-73. PubMed ID: 22689927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.
    Wilcox KM; Lindsey KP; Votaw JR; Goodman MM; Martarello L; Carroll FI; Howell LL
    Synapse; 2002 Jan; 43(1):78-85. PubMed ID: 11746736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.
    Jin H; Zhang X; Yue X; Liu H; Li J; Yang H; Flores H; Su Y; Parsons SM; Perlmutter JS; Tu Z
    Nucl Med Biol; 2016 Feb; 43(2):131-9. PubMed ID: 26872437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Evaluation of
    Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
    J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
    [No Abstract]   [Full Text] [Related]  

  • 12. [18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter.
    Lundkvist C; Halldin C; Ginovart N; Swahn CG; Farde L
    Nucl Med Biol; 1997 Oct; 24(7):621-7. PubMed ID: 9352532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2beta-carbo-1'-fluoro-2-propoxy-3beta-(4-chlorophenyl)tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography.
    Xing D; Chen P; Keil R; Kilts CD; Shi B; Camp VM; Malveaux G; Ely T; Owens MJ; Votaw J; Davis M; Hoffman JM; BaKay RA; Subramanian T; Watts RL; Goodman MM
    J Med Chem; 2000 Feb; 43(4):639-48. PubMed ID: 10691690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rate of dasotraline brain entry is slow following intravenous administration.
    Lew R; Constantinescu CC; Holden D; Carson RE; Carroll V; Galluppi G; Koblan KS; Hopkins SC
    Psychopharmacology (Berl); 2020 Nov; 237(11):3435-3446. PubMed ID: 32813030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion occupancy of the dopamine transporter is low during clinical treatment.
    Meyer JH; Goulding VS; Wilson AA; Hussey D; Christensen BK; Houle S
    Psychopharmacology (Berl); 2002 Aug; 163(1):102-5. PubMed ID: 12185406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo dopamine transporter imaging in a unilateral 6-hydroxydopamine rat model of Parkinson disease using 11C-methylphenidate PET.
    Sossi V; Dinelle K; Jivan S; Fischer K; Holden JE; Doudet D
    J Nucl Med; 2012 May; 53(5):813-22. PubMed ID: 22492730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 2alpha-tropane amides as potential PET ligands for the dopamine transporter.
    Drewes B; Sihver W; Willbold S; Olsson RA; Coenen HH
    Nucl Med Biol; 2007 Jul; 34(5):531-9. PubMed ID: 17591553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys.
    Wilcox KM; Kimmel HL; Lindsey KP; Votaw JR; Goodman MM; Howell LL
    Synapse; 2005 Dec; 58(4):220-8. PubMed ID: 16206183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo.
    Madras BK; Fahey MA; Goulet M; Lin Z; Bendor J; Goodrich C; Meltzer PC; Elmaleh DR; Livni E; Bonab AA; Fischman AJ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):570-85. PubMed ID: 16885433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.